FDA Complicity in Chemical Infanticide Exposes Apostate State’s Moral Bankruptcy
Catholic News Agency portal reports (December 10, 2025) on allegations that Food and Drug Administration Commissioner Marty Makary delayed safety reviews of the abortion drug mifepristone until after midterm elections. While Health and Human Services denies these claims as “baseless,” pro-life advocates including Sen. Josh Hawley demand reinstatement of safety regulations removed under the Biden administration. The article notes two peer-reviewed studies showing 10% of women experience serious adverse effects from chemical abortions, while Live Action’s Lila Rose insists “The FDA must act NOW to protect children and their mothers.”









